MorphoSys Ag (NASDAQ: MOR)
MorphoSys Ag Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
MorphoSys Ag Company Info
MorphoSys AG operates as a commercial-stage biopharmaceutical company. It uses groundbreaking science and technologies to discover, develop, and deliver innovative cancer medicines to patients. The firm also engages in the development and commercialization of therapeutic antibodies for patients suffering from cancer and autoimmune diseases. The company was founded by Andreas Pluckthun and Simon E. Moroney in July 1992 and is headquartered in Planegg, Germany.
News & Analysis
Why Shares of MorphoSys Are Up Wednesday
The company's phase 3 trial for a lead therapy is ahead of schedule.
Why MorphoSys Stock Sank This Week
Investors weren't happy about the drugmaker's wheeling and dealing.
Valuation
Earnings Transcripts
MorphoSys AG (MOR) Q2 2022 Earnings Call Transcript
MOR earnings call for the period ending June 30, 2022.
MorphoSys AG (MOR) Q1 2022 Earnings Call Transcript
MOR earnings call for the period ending March 31, 2022.
MorphoSys AG (MOR) Q4 2021 Earnings Call Transcript
MOR earnings call for the period ending December 31, 2021.
MorphoSys AG (MOR) Q3 2021 Earnings Call Transcript
MOR earnings call for the period ending September 30, 2021.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.